Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Safeguard Scientifics SFE -- Ignore unavailable to you. Want to Upgrade?

To: Wigglesworth who wrote (1567)	8/3/1998 1:20:00 PM
From: still learning	Respond to of 4467

Another SFE company: Monday August 3, 8:30 am Eastern Time Company Press Release SOURCE: QuestOne Decision Sciences Corporation Healthcare Executive to Lead Next Generation of Decision Sciences; Arnold N. Burstein Appointed President of QuestOne's Healthcare Division WALL TOWNSHIP, N.J., Aug. 3 /PRNewswire/ -- QuestOne Decision Sciences Corporation, developer of a proprietary decision science management technology that is already generating millions of dollars in new product development gains for Fortune 100 companies, announced the appointment of Arnold N. Burstein as President of its Healthcare Division. ''Past management systems are outdated, ineffective and just don't work anymore,'' said President Keith Krentz of QuestOne. ''Our decision science technology is the future of business. We are delighted to have Arnold joining us.'' With more than twenty-five years of successful experience in healthcare marketing, business development and manufacturing operations, Mr. Burstein will assume overall marketing and management responsibilities for the healthcare division of QuestOne. Before joining QuestOne, Mr. Burstein was President of E.A.B. Industries, a healthcare industry consulting firm concentrating on strategic market development. Previously Mr. Burstein spent twenty years with Schering-Plough and held key executive positions, including Vice President of Marketing for New Products, and Vice President of Business Planning, where he earned a reputation as a strategic innovator in product launches and new business development. While at Schering, Mr. Burstein designed and instituted a profitable contract manufacturing business unit. A resident of New Jersey for 20 years, Mr. Burstein is a frequent lecturer and writer on pharmaceutical management issues, and has taught at Fairleigh Dickinson University as an adjunct professor in their graduate pharmaceutical marketing program. Mr. Burstein resides in Wall Township, N.J. QuestOne utilizes a proprietary technology that identifies the constraints in a company's system -- the ''rust in the pipeline'' -- and deploys solutions that maximize resource potential, shorten the product development cycle and get products to market faster. Developed by two enterprise research professors at Lehigh University's Iacocca Institute, QuestOne is the next generation of decision sciences with far-reaching applications. QuestOne has the backing of one of the most prestigious venture capital corporations in the industry, Safeguard Scientifics, Inc. (NYSE: SFE - news). Based in Wayne, Pennsylvania, Safeguard is an unmatched partnership of entrepreneurial companies focused on information technology. Safeguard has a proven track record of bringing emerging companies to market through rights offerings to Safeguard shareholders. Past Safeguard rights offerings include Novell, Inc., CompuCom Systems, Inc., Cambridge Technology Partners (Massachusetts), Inc., Coherent Communications Systems Corporation, USDATA Corporation, Integrated Systems Consulting Group, Inc., Sanchez Computer Associates, Inc., Diamond Technology Partners, Inc., and ChromaVision Medical Systems, Inc.